AVNS
Avanos Medical, Inc. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -4.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 79 | +1 | 26.26M | $650.94M | +10 | −9 |
| Q1 2026 | 81 | -1 | 26.75M | $374.51M | +2 | −3 |
| Q4 2025 | 82 | 0 | 30.47M | $342.19M | +2 | −2 |
| Q3 2025 | 15 | -1 | 19.76M | $228.46M | — | −1 |
| Q2 2025 | 13 | -1 | 16.90M | $206.81M | — | −1 |
| Q1 2025 | 11 | -1 | 5.14M | $73.66M | +1 | −2 |
| Q4 2024 | 12 | 0 | 4.33M | $68.85M | +1 | −1 |
| Q3 2024 | 11 | 0 | 2.55M | $61.16M | — | — |
| Q2 2024 | 11 | — | 2.57M | $51.15M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 1.96M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.04M | -1.2% | $16.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.04M | -1.2% | $16.58M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 494.63K | +43.1% | $7.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 494.63K | +43.1% | $7.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 259.42K | -43.0% | $4.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 131.77K | -5.4% | $2.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (pasivo) | 104.50K | -40.0% | $1.66M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 90.04K | -21.7% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 72.70K | +20.6% | $1.16M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 64.77K | Nuevo | $1.03M | 0.0% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 64.77K | Nuevo | $1.03M | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 44.91K | -31.1% | $715,000 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 33.42K | -66.2% | $532,015 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 28.23K | +5.3% | $449,485 | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $1.03M | 0.0% |
| Marshall Wace | $1.03M | 0.0% |
Posición cerrada
| Bridgewater Associates | $251,618 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 255 tenedores, 44.71M acciones, $512.85M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.